Kizzmekia Corbett

Kizzmekia Corbett is a faculty member at Harvard University's T.H. Chan School of Public Health, where she continues her groundbreaking work in vaccine development. She previously served as the scientific lead of the coronavirus team at the Vaccine Research Center, part of the U.S. National Institute of Allergy and Infectious Diseases (NIAID), where she played a central role in developing mRNA vaccine technology used in the Moderna COVID-19 vaccine.

Her educational background includes a B.S. and M.S. in Biological Sciences and Sociology from the University of Maryland, Baltimore County (UMBC), where she was a Meyerhoff Scholar and NIH Scholar. Her training bridged scientific and social perspectives, shaping her commitment to health equity.

Dr. Corbett's research focuses on virology, immunology, and mRNA-based vaccines, with a strong emphasis on combating infectious diseases and reducing health disparities. Her work lies at the intersection of molecular biology and public health, aiming to ensure equitable access to life-saving vaccines.

While no specific publications are listed in the source text, her contributions are central to the advancement of mRNA vaccine platforms, which are now being explored for influenza and other pathogens, indicating a research trajectory in next-generation vaccine design and pandemic preparedness.

• Awards:
• TIME Magazine Hero of the Year

Dr. Corbett is deeply committed to mentorship, continuing the legacy of the Meyerhoff Scholars Program by supporting emerging scientists such as Olubukola Abiona. Although specific grants are not mentioned, her leadership role at NIAID and current position at Harvard suggest sustained funding and research support. She exemplifies the integration of scientific excellence with social responsibility.

She is associated with research teams at both the Vaccine Research Center at NIAID and the Harvard T.H. Chan School of Public Health, where she leads efforts in vaccine innovation and public health advocacy.